tradingkey.logo
tradingkey.logo
Search

Arcturus Therapeutics Holdings Inc

ARCT
Add to Watchlist
14.120USD
+0.820+6.17%
Close 09-24 16:00(ET)
401.29MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D

Today

+6.17%

5 Days

-16.60%

1 Month

-1.53%

6 Months

+112.33%

Year to Date

+130.34%

1 Year

-30.95%

Key Figures

13.940Open
14.610High
135.84KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.48%Turnover Ratio
13.300Prev. Close
13.260Low
1.92MTurnover
LossP/E Static
2.34P/B
0.00%Div Yield TTM
-27.26%ROA
24.17052wk High
0.13Volume Ratio
-80.94MNet Profit
28.42MShares
-2.8315EPS TTM
2.37Beta
-37.01%ROE
5.50052wk Low
10.15%Amplitude
100.00%Gross Margin
401.29MMarket Cap
9.41Reward/Risk
5.84%Risk Rate
More news coming soon, stay tuned...

Arcturus Therapeutics Holdings Inc's Score

0.07vs previous score
Forecast8.00
Financial Health6.28
Technical4.86
Valuation Dimensions7.28
Institutional Confidence7.00
Risk Assessment3.26

Media Coverage

Coverage Level

Very Low
Very High
Positive

Analyst Rating

Strong Buy
Buy
Hold
Sell
Strong Sell
BuyCurrent Rating
22.000Target Price
+65.41%Upside Space
Current Rating2026-092026-082026-072026-062026-052026-042026-032026-02
Strong Buy33333333
Buy66776655
Hold33333333
Sell00000000
Strong Sell00000000

Arcturus Therapeutics Holdings Inc Technical Analysis

1m
5m
15m
30m
1h
2h
4h
D
W
M
1m
5m
15m
D

Technical Indicators

Sell

Summary

Neutral

Moving Average

Neutral

Financial Indicators

Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Earnings

Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.84/-1.00
Revenue / Forecast
2.96M/3.20M

Arcturus Therapeutics Holdings Inc Profile

SectorBiotechnology & Medical Research
Ticker SymbolARCT
Number of employees174
CountryUnited States of America

Ownership

ShareholdersProportion
Federated Hermes Global Investment Management Corp.11.62%
ARK Investment Management LLC9.74%
Amova Asset Management Co., Ltd.8.05%
BlackRock Institutional Trust Company, N.A.7.46%
Shareholder TypesProportion
Investment Advisor/Hedge Fund34.57%
Investment Advisor33.08%
Individual Investor7.99%
Hedge Fund7.96%

FAQs

What is the current price of Arcturus Therapeutics Holdings Inc (ARCT)?

The current price of Arcturus Therapeutics Holdings Inc (ARCT) is 14.12.

What is the symbol of Arcturus Therapeutics Holdings Inc?

The ticker symbol of Arcturus Therapeutics Holdings Inc is ARCT.

What is the 52-week high of Arcturus Therapeutics Holdings Inc?

The 52-week high of Arcturus Therapeutics Holdings Inc is 24.17.

What is the 52-week low of Arcturus Therapeutics Holdings Inc?

The 52-week low of Arcturus Therapeutics Holdings Inc is 5.50.

What is the market capitalization of Arcturus Therapeutics Holdings Inc?

The market capitalization of Arcturus Therapeutics Holdings Inc is 401.29M.

Is Arcturus Therapeutics Holdings Inc (ARCT) currently rated as Buy, Hold, or Sell?

According to analysts, Arcturus Therapeutics Holdings Inc (ARCT) has an overall rating of Buy, with a price target of 22.00.

What is the Earnings Per Share (EPS TTM) of Arcturus Therapeutics Holdings Inc (ARCT)?

The Earnings Per Share (EPS TTM) of Arcturus Therapeutics Holdings Inc (ARCT) is -2.83.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.